Northwind Pharmaceuticals

Great Night for Northwind, Butler and Gennesaret Free Clinics!

Thank you to all who were able to participate in the Northwind Christmas Celebration at Hinkle Fieldhouse last night!  Butler University’s Hinkle Fieldhouse provided the backdrop to an evening of fun, connection and charity.  Guests enjoyed food, conversation and behind-the-scenes tours of Hinkle while supporting Gennesaret Free Clinics,  an organization dedicated to healing here in the heart of Indianapolis. We feel tremendous gratitude for our many blessings this Christmas Season and wish everyone peace and prosperity as we head into 2015.

  IMG_1231IMG_1236GROUP3GROUP4GROUP2

Phillip Berry
Schedule a free claims analysis now.

Let’s Talk now

Leader in AI-driven health benefits navigation Healthee partners with Northwind

Katherine Lurk | Mar 28th, 2025
A game-changer for employers looking to cut costs and gain control With healthcare costs continuing to rise, employers are seeking new ways to rein in spending without sacrificing the quality of benefits. This partnership enables Healthee clients to optimize prescription drug management, reducing costs through preferable generic drug pricing, high-touch chronic care programs, and more. … more »

continue reading

Healthcare Storm 2025: What Will It Be?

Phillip Berry | Jan 1st, 2025
When it comes to American healthcare, we’ve become really good at highlighting its failings. Watching the flurry of lamentations, frustrations, denigrations, and prognostications, over the last few weeks, would lead any rational person to believe that nothing is working in our healthcare system. And, not only is it “not working,” many people conclude that it … more »

continue reading

New Drugs to Market – October Update

Phillip Berry | Oct 25th, 2024
The Food and Drug Administration (FDA) approved three novel drug therapies in October. One of those therapies,  Hympavzi (marstacimab-hncq), is a medication indicated for the treatment of patients with Hemophilia A and Hemophilia B. Hympavzi utilizes a new pathway to help reduce the risk of bleeding episodes in patients with Hemophilia, a disease that impacts … more »

continue reading